Novel biochemical predictors of unfavorable prognosis for stable coronary disease

about

Novel biochemical predictors of unfavorable prognosis for stable coronary disease

Item

http://www.wikidata.org/entity/Q58739842

description

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Novel biochemical predictors of unfavorable prognosis for stable coronary disease

@en

Novel biochemical predictors of unfavorable prognosis for stable coronary disease

@nl

type

Item

label

Novel biochemical predictors of unfavorable prognosis for stable coronary disease

@en

Novel biochemical predictors of unfavorable prognosis for stable coronary disease

@nl

prefLabel

Novel biochemical predictors of unfavorable prognosis for stable coronary disease

@en

Novel biochemical predictors of unfavorable prognosis for stable coronary disease

@nl

P1476

Novel biochemical predictors of unfavorable prognosis for stable coronary disease

@en

P2093

Agnieszka Kondracka

http://www.w3.org/2001/XMLSchema#string

Andrzej Cacko

http://www.w3.org/2001/XMLSchema#string

Grzegorz Opolski

http://www.w3.org/2001/XMLSchema#string

Krzysztof J Filipiak

http://www.w3.org/2001/XMLSchema#string

Monika Gawałko

http://www.w3.org/2001/XMLSchema#string

Renata Główczyńska

http://www.w3.org/2001/XMLSchema#string

Zbigniew Bartoszewicz

http://www.w3.org/2001/XMLSchema#string

P2860

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs.

Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing.

Procalcitonin testing for diagnosis and short-term prognosis in bacterial infection complicated by congestive heart failure: a multicenter analysis of 4,698 cases.

Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis.

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevati

How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study.

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribut

B-type natriuretic peptides for the prediction of cardiovascular events in patients with stable coronary heart disease: the Heart and Soul Study.

P304

e12372

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000012372

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marcin Grabowski

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30212999

http://www.w3.org/2001/XMLSchema#string

P932

6155940

http://www.w3.org/2001/XMLSchema#string